Publications
- Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA2022 | First Faculty of Medicine, Second Faculty of Medicine
- Self-perceived general health at start of TNFi therapy predicts therapeutic response in patients with rheumatoid arthritis: analysis from the ATTRA registry2022 | Central Library of Charles University, First Faculty of Medicine
- Achieving the goal of rheumatoid arthritis treatment is more common in patients with moderate activity than high disease activity in the real clinical practice of the ATTRA National Registry of Biological Treatment2022 | Central Library of Charles University, First Faculty of Medicine
- The beneficial effect of csDMARDs co-medication on drug persistence of first-line TNF inhibitor in rheumatoid arthritis patients: data from Czech ATTRA registry2022 | First Faculty of Medicine
- Dlouhodobé výsledky léčby baricitinibem v českém národním registru ATTRA2022 | First Faculty of Medicine
- Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry2021 | Central Library of Charles University, First Faculty of Medicine
- Baricitinib in the treatment of rheumatoid arthritis in routine clinical practice - results from the Czech National ATTRA Registry2021 | Central Library of Charles University, First Faculty of Medicine
- How biological treatment affects the ability to work in patients with axial spondyloarthritis - results from ATTRA, the Czech national registry2021 | First Faculty of Medicine
- Gender difference in disease severity and treatment outcomes among patients with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) starting treatment with targeted therapies in the Czech Republic - analysis from the nation-wide ATTRA registry of biological therapy2021 | First Faculty of Medicine
- Gender difference in disease severity and treatment outcomes among patients with rheumatoid arthritis (RA), axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) treated for one year with certolizumab pegol - analysis from the nationwide ATTRA registry of biological therapy2021 | First Faculty of Medicine
Loading network view...